Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial. It's a ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

Spinal cord stimulation has been available as a chronic pain treatment for decades, but even now, Medtronic—which was the first to make the implants commercially available in the late 1960s—is still ...

DENVER, Colo. (Ivanhoe Newswire) - A growing crisis is gripping the nation—millions of Americans are living in severe pain and turning to prescription painkillers for help. The CDC reports 20 percent ...

University of Pittsburgh School of Medicine researchers carrying out a small pilot clinical trial demonstrating that a drug-free, minimally invasive intervention targets the root cause of progressive ...